InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: None

Monday, 10/17/2016 1:00:39 PM

Monday, October 17, 2016 1:00:39 PM

Post# of 48316
It's important to remember what OncoSec is up against.
PHASE I: Approximately 70% of drugs move to the next phase
PHASE II: Approximately 33% of those drugs move to the next phase
PHASE III: Approximately 25-30% of drugs move to the next phase

That means out of every 1000 drugs in development only 57 out of a 1000 make it. This upcoming PHASE IIB interim data is very important with these kind of odds. I still would prefer a buyout and let Big Pharma assume the risk of further development.